Despite a subdued quarter, most companies gave a strong outlook going forward, with demand expected to improve from Q2FY2022
A temporary breather after ~8% rally over the past four weeks would present an incremental buying opportunity to build a quality portfolio.
In early deals, Sensex lost 67.12 points or 0.12% at 55,881.98, while the Nifty 50 declined 6.95 points or 0.04% at 16,629.95
After swinging between gains and losses, the 30-share BSE index settled at 55,949.10, up 4.89 points or 0.01%
Affle India board approved stock split (sub-division of equity shares) in the ratio of 1:5, to facilitate larger shareholder base and aid liquidity.
Linde India has turned out to be a multibagger for investors as it has rallied 183% since the beginning of 2021.
The price band for Vijaya Diagnostic Centre has been fixed at Rs 522-531 per share having a face value of Rs 1 per share.
In early deals, Sensex was at 55,935 down 8 points or 0.02%, while the Nifty 50 fell 21 points or 0.13% at 16,613
Meghmani Finechem stock price: On BSE, the stock hit Rs 492.95, as against the listing price of Rs 405.65, an increase of 21.5%.
Sensex failed to hold 56k-mark and settled 14.77 or 0.03% lower at 55,944.21, while Nifty closed at 16,634.65, up 10.05 points or 0.06%